New research from Emory University reveals that nasal autoantibodies in COVID-19 patients may help predict disease severity, with potential implications for treatment. COVID-19 symptoms vary widely, from mild to severe. While current virus strains tend to cause milder cases, people with underlying health conditions remain at a significantly higher risk for severe illness. New research […]
Source link